Some antigens have been previously proposed as potential synthetic vaccines against leishmaniasis, like KMP-11 recognized by human CD8+ lymphocytes and by many different HLA receptors (41), or Leish110f fusion protein (42). This evidence concerns the gene CD8A and leishmaniasis.